New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 19, 2013
04:55 EDTLIFE, LIFE, LIFE, SI, SI, SI, BIOL, BIOL, BIOL, IVC, IVC, IVC, VAR, VAR, VAR, ARAY, ARAY, ARAY, CPHD, CPHD, CPHD, MASI, MASI, MASI, HRC, HRC, HRC, RHHBY, RHHBY, RHHBY, MCK, MCK, MCKWorldwide Business Research to host a conference
Field Service Medical Conference is being held in San Diego on February 19-21.
News For LIFE;RHHBY;HRC;MASI;CPHD;ARAY;VAR;IVC;BIOL;SI;MCK From The Last 14 Days
Check below for free stories on LIFE;RHHBY;HRC;MASI;CPHD;ARAY;VAR;IVC;BIOL;SI;MCK the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
July 23, 2014
16:28 EDTVARVarian Medical sees Q4 EPS $1.14-$1.29, consensus $1.26
Subscribe for More Information
16:26 EDTVARVarian Medical reports Q3 EPS with items $1.02, consensus $1.09
Subscribe for More Information
09:08 EDTRHHBYUltragenyx appoints Sunil Agarwal, M.D. as Chief Medical Officer
Subscribe for More Information
July 22, 2014
08:02 EDTVARVarian Medical announces certification of ARIA oncology information system
Subscribe for More Information
05:21 EDTRHHBYRoche announces Genentech Avastin granted priority review by FDA
Subscribe for More Information
July 21, 2014
09:08 EDTBIOLBIOLASE sells 6.25M shares at $1.92 in a private placement
Subscribe for More Information
08:01 EDTVARVarian Medical receives FDA clearance for Calypso Beacon transponder
Subscribe for More Information
07:14 EDTVAR, ARAYAmerican Association of Physicists in Medicine to hold annual meeting
56th Annual Meeting of AAPM to be held in Austin, Texas on July 20-25.
07:11 EDTRHHBYInternational Society of DNA Vaccines to hold a conference
Subscribe for More Information
06:43 EDTRHHBYGrowing market for hepatitis-C treatment prompts legal scramble, WSJ says
Subscribe for More Information
July 20, 2014
15:42 EDTRHHBYRoche not looking for big acquisitions, Reuters says
Subscribe for More Information
July 18, 2014
09:44 EDTCPHDCepheid trades sharply lower after earnings, levels to watch
Subscribe for More Information
09:24 EDTCPHDOn The Fly: Pre-market Movers
Subscribe for More Information
July 17, 2014
17:42 EDTRHHBY, CPHDCepheid says Roche patent suit will not have material adverse impact on results
Subscribe for More Information
17:31 EDTCPHDCepheid sees significant step up in Q4 revenue
17:31 EDTCPHDCepheid sees Q3 non-GAAP EPS (1c)-1c, consensus (8c)
Subscribe for More Information
16:14 EDTCPHDCepheid sees FY14 adjusted EPS 10c-13c, may not compare to consensus (37c)
Subscribe for More Information
16:13 EDTCPHDCepheid reports Q2 EPS (14c), consensus (14c)
Reports Q2 revenue $116.5M, consensus $115.56M.
July 16, 2014
11:23 EDTRHHBYRoche Alzheimer drug shows mixed results in trial, NYT says
Subscribe for More Information
06:26 EDTRHHBYBristol-Myers lung cancer trials being underestimated, says Citigroup
After building a statistical model of Bristol-Myers' two critical registration trials for Opdivo in lung cancer, Citigroup believes the market is "materially" underestimating both Phase III trials. Citi says potential Opdivo FDA approval in 2015 in lung cancer would give Bristol-Myers an up to two year lead time versus Merck (MRK) and Roche (RHHBY). The firm estimates 2023 Opdivo revenue at $7B and reiterates a Buy rating on Bristol with a $60 price target.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use